Table 1 Baseline characteristics of the participants
Characteristics | Trajectory sample (n = 14,373) | Prospective sample (n = 12,129) |
|---|---|---|
Age, y | 56.3 ± 8.1 | 63.3 ± 7.3 |
Sex | ||
Women, n (%) | 7839 (54.5) | 6750 (55.7) |
Men, n (%) | 6534 (45.5) | 5379 (44.4) |
Race | ||
White/Caucasian | 9593 (66.7) | 8140 (67.1) |
African American/Black | 3138 (22.0) | 2605 (21.5) |
Hispanic/Latino | 1044 (7.3) | 889 (7.3) |
Asian/Chinese | 571 (4.0) | 495 (4.1) |
Body mass index, kg/m2 | 27.6 (5.2) | 28.4 (5.5) |
Total cholesterol, mg/dL | 206.7 (39.4) | 197.3 (36.7) |
LDL cholesterol, mg/dL | 129.9 (36.8) | 119.3 (33.1) |
HDL cholesterol, mg/dL | 52.2 (16.2) | 51.7 (16.3) |
Triglycerides, mg/dL | 122.7 (63.6) | 132.8 (77.4) |
Systolic blood pressure, mmHg | 120.9 (18.5) | 125.1 (19.0) |
Diastolic blood pressure, mmHg | 72.5 (10.4) | 70.6 (9.9) |
Hypertension | 4585 (32.0) | 5271 (43.5) |
Antihypertensive drug | 3810 (26.5) | 4586 (37.8) |
Lipid-lowering drug use | 2609 (18.2) | 3799 (31.3) |
Diabetes mellitus | 1269 (8.8) | 1730 (14.3) |
Current smoking | 2634 (18.4) | 1569 (12.9) |
Current drinking | 8510 (59.5) | 6114 (50.4) |